Mercer Island, WA, United States of America

Phillip D Greenberg

This inventor holds 1 USPTO granted patent. Top assignees: Fred Hutchinson Cancer Center, Immunex Corporation. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phillip D Greenberg. Retrieved from https://idiyas.com/inventor/phillip-d-greenberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Phillip D Greenberg

Introduction

Phillip D Greenberg is a notable inventor based in Mercer Island, WA (US). He has made significant contributions to the field of immunology, particularly in the development of cytotoxic T lymphocytes (CTLs). His innovative work has implications for cancer treatment and immune response.

Latest Patents

Phillip D Greenberg holds a patent for a "Method for producing T.sub.H -independent cytotoxic T lymphocytes." This invention relates to CTLs that have been converted to a helper T cell independent phenotype by introducing a recombinant expression vector encoding IL-1 receptor into the CTL. The resulting CTLs possess the ability to grow or function independently of T cell help, which is a significant advancement in immunotherapy.

Career Highlights

Throughout his career, Greenberg has worked with prominent organizations such as Immunex Corporation and Fred Hutchinson Cancer Center. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable coworkers is Robert W Overell. Their collaboration has likely fostered advancements in their shared research interests.

Conclusion

Phillip D Greenberg's contributions to the field of immunology through his innovative patent and career highlights demonstrate his commitment to advancing medical science. His work continues to influence the development of new therapies for cancer and immune-related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…